3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Breast Neoplasms
2
Thymus Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Mesothelioma
1
Melanoma
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Adenocarcinoma
1
Interventions
trametinib
5
dabrafenib
5
pembrolizumab
3
lenvatinib
3
cobimetinib
2
cemiplimab
2
atezolizumab
2
Vemurafenib
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
zimberelimab
1
selpercatinib
1
fludarabine
1
cabozantinib
1
aldesleukin
1
Taxes
1
Ipilimumab
1
Immunoglobulin G
1
Disulfides
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Histocompatibility Testing
×
1 year
×
Clear all
No trials found.